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Abstract The presence of Lewy bodies (LB) in auto-
nomic structures of the central and peripheral nervous sys-
tem in Parkinson’s disease (PD) is well known and could
explain clinical signs of pure autonomic failure (PAF) or
dysphagia, frequently associated with the disorder. There
are many neuropathological reports in the literature with
detailed descriptions of PAF, however, LB dysphagia has
thus far only been reported once. In the present study, we
describe two cases of isolated dysphagia without extrapyra-
midal syndrome, diagnosed clinically as progressive supra-
nuclear palsy and amyotrophic lateral sclerosis, where
detailed neuropathological examination identiWed LBs in
the dorsal vagal motor nuclei in the medulla. These Wndings
conWrm the existence of isolated LB dysphagia and empha-
size the importance of detailed neuropathological and
immunohistochemical examination in cases of dysphagia.
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Introduction
Swallowing relies on complex voluntary and involuntary
innervation of striated and smooth muscles via cranial
nerves. Normal swallowing with simultaneous protection
of the respiratory system needs the coordinated action of
both autonomic and somatomotor systems, including cra-
nial nerves (V, VII, IX, X, XI and XII) and large groups of
striated and smooth muscles [20].
Dysfunction of swallowing may be due to cortical, bul-
bar, or cerebellar brain damage or to diseases of peripheral
nerves and muscles. In elderly persons, dysphagia occurs
frequently as pseudobulbar palsy in cerebrovascular dis-
ease, or as an accompanying sign of neurodegenerative
disorders, i.e. Parkinson’s disease (PD), multiple system
atrophy (MSA), progressive suparanuclear palsy (PSP),
corticobasal degeneration and amyotrophic lateral sclerosis
(ALS) [20].
Swallowing abnormalities are common problems in
these degenerative disorders. Usually, dysphagia appears
earlier in the course of PSP and MSA than in PD [13]: the
onset within the Wrst year of disease is characteristic of
atypical parkinsonian syndromes [13]. However, it is often
seen in the earliest stages of PD [14, 15]. The reported inci-
dence of swallowing dysfunction in PD ranges from 30
to 52% [15]. Symptoms correlate with disease severity and
duration [4] and are associated with increased morbidity
and mortality [12].
Although the presence of Lewy body (LB) pathology in
the cranial nerve nuclei IX/X is well known in PD cases
presenting swallowing dysfunction, there is only one neuro-
pathological report in the literature concerning two cases
with LB dysphagia [12]. Our paper describes two patients
with isolated dysphagia, where neuropathological examina-
tion conWrmed LB pathology at the medullary level.
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Clinical summary
Case 1
This 89-year-old man developed dysphagia 4 years prior to
death. He had multiple transient ischemic attacks (TIA) in a
setting of auricular Wbrillation with anticoagulation treat-
ment. He suVered two novel TIAs 2 months before death,
Wrst with right hemiparesis; the second time 4 days later
with paresis of the right arm and dysarthria. Neurological
examination revealed a severe hypophonia and dysphagia,
prompting a clinical suspicion of PSP with aVection of cra-
nial nerve X, but no further investigations were performed.
The CT scan showed hypodensities in the left Sylvian and
insular regions, possibily representing brain infarcts. He
died of bronchopneumonia, conWrmed by autopsy. Other
autopsy Wndings were moderate atherosclerosis, pulmonary
emphysema, and cardiac hypertrophy.
Case 2
An 86-year-old man was admitted to the hospital because
of dyspnea, auricular Wbrillation and suspicion of pulmo-
nary abscess. In his anamnesis dysphagia was noted, begin-
ning 2 years before death and progressing to aphagia. The
performed oesophagogastroduodenoscopy did not yield
any explication for dysphagia. The rest of his neurological
status was normal. The clinical diVerential diagnosis
included pseudobulbar palsy and amyotrophic lateral sclerosis
(ALS). He died due to bronchopneumonia. The systemic
autopsy revealed bilateral bronchopneumonia with empy-
ema, pulmonary emphysema, mild atherosclerosis, cardiac
hypertrophy, and a tubular adenoma of the colon.
Materials and methods
Brains obtained at autopsy were Wxed in 15% formalin for
4 weeks and stored in 5% formalin. After macroscopic
examination, both hemispheres were cut into 1-cm-thick
coronal slices. For histological examination and immuno-
histochemistry, tissue blocks were taken from the frontal
cortex (area 9), the middle temporal gyrus (area 21), the
anterior cingulate cortex (area 24), the parietal cortex (area
40), the transentorhinal cortex, substantia nigra, pons at the
level of locus coeruleus, and medulla at the level of inferior
olive. Samples were embedded in paraYn and cut into 14-
m-thick sections. Serial sections were stained consecu-
tively with haematoxylin–eosin, cresyl-violet and with the
following antibodies: AT8 (mouse, monoclonal, Innogenet-
ics, Gent, Belgium; 1:3,000), anti-ubiquitin (rabbit, polyclonal,
Sigma; 1:100), anti--synuclein (mouse, monoclonal, Zymed,
1:3,000) and monoclonal antibody against core amyloid
A protein 4G8 (mouse, monoclonal, Signet Laboratories,
Dedham, MA, USA; 1:2,000).
Neuropathology
Case 1
The brain weight was 1380 g. With exception of a severe
atherosclerosis, the brain did not show any macroscopic
lesions. No brain infarct was present, but the white matter
showed moderate demyelination. In the substantia nigra a
LB was observed in one neuron accompanied by some
Lewy neurites (LN), without appreciable neuron loss
(Fig. 1a, c, d). Both dorsal vagal motor nuclei—without
signiWcant neuronal loss—(Fig. 1g, h), the obscure raphe
nucleus (Fig. 1i), the intermediate reticular zone, the
nucleus ambiguus and the locus coeruleus (Fig. 1j) also
contained some LBs and LNs. The hypoglossal nuclei were
free of inclusions. In other regions of the brainstem and
cortical areas -synuclein containing inclusions were
absent. Amyloid deposits were absent and only the hippo-
campus and entorhinal cortex showed some neuroWbrillary
tangles.
Case 2
The brain weighed 1350 g. Macroscopic examination
revealed only the following lesions: a mild frontal atrophy,
a 2 mm diameter lacune in the left putamen and an old 4 cm
diameter infarct in the right occipital lobe around the calc-
arine Wssure.
The substantia nigra did not show any neuronal loss or
-synuclein-inclusions (Fig. 1b), however, the locus coeru-
leus contained a few LBs and LNs (Fig. 1e, f). Histological
examination also showed the presence of -synuclein-posi-
tive inclusions in the absence of neuronal loss in the dorsal
vagus motor nuclei and in the intermediate reticular zone.
LBs and LNs were absent in the nucleus ambiguus or other
structures at the medullary level. NeuroWbrillary tangles
were scarce and restricted to the entorhinal cortex and the
CA1 Weld of hippocampus. Mild amyloid deposition was
noted only in the parietal neocortex.
Discussion
Above, we present two cases of isolated dysphagia with a
suspected clinical diagnosis of PSP and ALS diagnosed
neuropathologically as LB dysphagia.
Lewy bodies (LB) were described as the pathological
hallmarks of idiopathic Parkinson’s disease (PD) [18].
Recently, it was recognised that they are present in other123
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ciated with PD. Idiopathic PD, LB dementia, autonomic
failure and LB dysphagia [6] form the spectrum of the LB
disorders—also called LB disease [9]. The clinical manifes-
tations of LB pathology depend on the severity and anatom-
ical distribution of LB involvement in the central and
peripheral nervous system [8]. The clinical signs of an
extrapyramidal syndrome, dysphagia or autonomic failure
could be explained by the presence of LBs in the substantia
nigra, dorsal vagal motor nuclei or sympathetic ganglia
respectively [5, 7].
In the topographical evolution of LB pathology in stage 1
LBs and LNs are seen in the medulla, in the nuclei of cranial
nerves IX and X and/or in the intermediate reticular zone;
in stage 2 additional -synuclein-positive inclusions appear
in the pontine tegmentum, in the caudal raphe nuclei, gig-
antocellular reticular nucleus, and coeruleus–subcoeruleus
complex [2]. A recent study described -synuclein-immu-
noreactive inclusions in the spinal cord lamina I neurons
preceding stage 1 in the evolution [3].
The neuroanatomical basis of dysphagia in PD—
mainly observed in the advanced stages of the disease—
is complex. The mechanism of swallowing dysfunction
may be explained in part by bradykinesia and rigidity in
the oral phase of swallowing [15]. In the pharyngeal and
esophageal phases, autonomic cranial nerves and the
Fig. 1 Absence of neuronal loss 
in the substantia nigra in both 
cases a case 1, b case 2. A 
unique LB (arrow) and some 
LNs in the substantia nigra of 
case 1 (c, d) and in the locus 
coeruleus of case 2 (e, f). LBs 
(arrow) and LNs in the dorsal 
vagal motor nucleus bilaterally 
(g, h), the obscure raphe nucleus 
(i) and the locus coeruleus (j) of 
case 1. Haematoxylin–eosin 
(a, b) immunohistochemistry 
anti--synuclein (c–j). Scale 
bar: a, b 400 m; c–f, h–j: 
100 m; g 700 m123
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nial nerve motor neurons (nucleus ambiguus and vagal
dorsal nucleus) innervating muscles of deglutition are
serially activated by the central pattern generator [11].
The nucleus ambiguus innervates pharyngeal striated
muscles; the dorsal vagal motor nucleus muscles of both
lower pharynx and oesophagus [10], therefore the degen-
eration of the dorsal vagal nucleus may be responsible for
both pharyngeal and oesophageal dysphagia.
Cases with incidental -synuclein-pathology are described
in the literature and their clinical importance is not yet
clariWed. In the olfactory system, where -synuclein-
positive lesions are present in the olfactory bulb early in the
course of PD, causing impaired smell sensation or anosmia
prior to the apparition of movement problems [1], a recent
study found a correlation between olfactory dysfunction
and incidental LB disease in the brainstem [16]. The
aVection of lamina I neurons in the spinal cord, having
extended connections with sympathetic relay centers, could
explain painful sensation not infrequently observed in PD
[3].
However, dysphagia and olfactory dysfunction may not
be clinically apparent, making retrospective neuropatholog-
ical studies impossible.
Although the presence of LBs in the dorsal vagal motor
nucleus is well known during the progression of PD, there
are only two cases reported of isolated LB dysphagia,
described by Jackson and colleagues in 1995 [7], corre-
sponding to low Braak stages of LB pathology.
The recognition of Braak stages 1 and 2, corresponding
to asymptomatic cases concerning extrapyramidal signs,
may escape clinical diagnosis, and after neuropathological
examination, could be diagnosed as incidental Wndings.
Great importance should be given to the examination of the
medulla in all cases with dysphagia to obtain the real fre-
quency of the disorder. Furthermore, dysphagia may be an
early hallmark of PD, similar to dysfunction of the olfac-
tory system.
Our cases were diVerent with regard to medullary
pathology. Case 1 showed -synuclein inclusions in both
dorsal vagal motor nucleus and the nucleus ambiguus
implying that both the pharyngeal and oesophageal phases
of swallowing were disturbed. In case 2, the restriction of
LBs to the dorsal vagal motor nucleus suggest aVection of
the late oesophageal phase [17]. The fact that the presented
patients never developed parkinsonian signs during the sev-
eral years (4 and 2 years) with dysphagia, supports that LB
dysphagia can be an entity and not only an accompanying
sign of PD and therefore underlines the importance of care-
ful neuropathological examination.
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